Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | SVP and CCO | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ROCKWELL MEDICAL, INC.
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,285 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 15,000 · Balance 27,285 F1: Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer. F2: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer.
F2: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 13:24 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047117 · wk-form4_1783344242.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,285 F1 · kind: Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 22:09 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 2,444 | $0.90 | $2,199.60 |
DisclosureSEC source: 0001628280-26-018315 · wk-form4_1773698967.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,855 F1 · kind: These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation. Read SEC document |
| October 01, 2025 Filed Oct 1, 2025 20:24 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 2,868 | $1.19 | $3,412.92 |
DisclosureSEC source: 0001628280-25-043434 · wk-form4_1759350273.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP and CCO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,299 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. The price reported above reflects the sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:22 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 2,868 | $0.82 | $2,351.76 |
DisclosureSEC source: 0001628280-25-034076 · wk-form4_1751491366.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,167 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024 in multiple trades at prices ranging from $0.80 to $0.83. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 17:28 UTC Amendment | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 2,868 | $0.82 | $2,351.76 |
DisclosureSEC source: 0001628280-25-034187 · wk-form4a_1751563685.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP and CCO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,167 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024 in multiple trades at prices ranging from $0.80 to $0.83. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 20, 2025 Filed May 21, 2025 23:01 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001104659-25-051707 · tm2515860-1_4seq1.xml · derivative · entry 2 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2035-05-20 F2 · derivative.exercise_date: Stock options vest 1/3 on the first anniversary of May 20, 2025, with the remaining vesting in equal monthly installments through May 20, 2028, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 20, 2025 Filed May 21, 2025 23:01 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-051707 · tm2515860-1_4seq1.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,035 F1 · kind: Restricted stock units vest on May 20, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 20, 2025 Filed Apr 17, 2026 22:50 UTC Amendment | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantPerformance-based restricted stock units · Derivative | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-045048 · tm2612183-2_4aseq1.xml · derivative · entry 1 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2028-05-20 F1 · derivative.exercise_price: These are performance-based restricted stock units ("PSU") with terms as follows. The term of each PSU award runs from the grant date through the third anniversary of the grant date. Any unvested PSUs remaining after the third anniversary will be cancelled. The performance period for the award is the same three-year period. PSUs will vest on or after the first anniversary of the grant date only if the stock price meets the performance hurdle. The performance hurdle is met if the average closing price of the Company's common stock over any 60 consecutive trading days during the performance period equals two times the base price. The base price was calculated as the average closing price over the ten trading days ending on the trading day prior to the grant date and is $2.14 for this award. F1 · kind: These are performance-based restricted stock units ("PSU") with terms as follows. The term of each PSU award runs from the grant date through the third anniversary of the grant date. Any unvested PSUs remaining after the third anniversary will be cancelled. The performance period for the award is the same three-year period. PSUs will vest on or after the first anniversary of the grant date only if the stock price meets the performance hurdle. The performance hurdle is met if the average closing price of the Company's common stock over any 60 consecutive trading days during the performance period equals two times the base price. The base price was calculated as the average closing price over the ten trading days ending on the trading day prior to the grant date and is $2.14 for this award. F1 · derivative.exercise_date: These are performance-based restricted stock units ("PSU") with terms as follows. The term of each PSU award runs from the grant date through the third anniversary of the grant date. Any unvested PSUs remaining after the third anniversary will be cancelled. The performance period for the award is the same three-year period. PSUs will vest on or after the first anniversary of the grant date only if the stock price meets the performance hurdle. The performance hurdle is met if the average closing price of the Company's common stock over any 60 consecutive trading days during the performance period equals two times the base price. The base price was calculated as the average closing price over the ten trading days ending on the trading day prior to the grant date and is $2.14 for this award. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 22:03 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 2,868 | $1.08 | $3,097.44 |
DisclosureSEC source: 0001104659-25-031295 · tm2511323-1_4seq1.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,035 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024 in multiple trades at prices ranging from $1.065 to $1.095. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:23 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 2,823 | $1.77 | $4,996.71 |
DisclosureSEC source: 0001104659-25-025180 · tm259684-3_4seq1.xml · nonDerivative · entry 2 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,903 F1 · kind: These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:23 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 2,444 | $1.70 | $4,154.80 |
DisclosureSEC source: 0001104659-25-025180 · tm259684-3_4seq1.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,726 F1 · kind: These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:44 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 1,001 | $2.05 | $2,052.05 |
DisclosureSEC source: 0001104659-25-001359 · tm252076-2_4seq1.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,170 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024 in multiple trades at prices ranging from $2.0401 to $2.0519. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 01:55 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 1,001 | $3.69 | $3,688.89 |
DisclosureSEC source: 0001104659-24-105581 · tm2425510-2_4seq1.xml · nonDerivative · entry 1 Chole Timothy · CIK 0002025169 · SVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,171 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024 in multiple trades at prices ranging from $3.67 to $3.69. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Due to an administrative error, the withholding of 2,823 shares to cover the estimated tax withholding obligation was erroneously omitted from the Form 3 filed on May 30, 2024. This form reflects the correct amount of common stock beneficially owned by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.